BTKi +humanized anti-CD20 for advanced follicular lymphoma: ready for an ALTERNATIVE?

BTKi +humanized anti-CD20 for advanced follicular lymphoma: ready for an ALTERNATIVE?

Not available.

Saved in:

Bibliographic Details
Main Authors:	Irene Dogliotti, Massimo Federico
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-07-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/12162
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Loss of CD20 Expression in Follicular Lymphoma after Program Anti-Tumor Therapy Including Rituximab: Literature Data and Case Report
by: OM Volodina, et al.
Published: (2017-04-01)

Radioimmunotherapy Combined with Maintenance Anti-CD20 Antibody May Trigger Long-Term Protective T Cell Immunity in Follicular Lymphoma Patients
by: Franz Buchegger, et al.
Published: (2013-01-01)

Investigation of the mechanism of hypertension caused by BTKi in the treatment of hematologic diseases
by: Jiayi Xu, et al.
Published: (2025-05-01)

The screening and anti-Raji lymphoma effect of Chiloscyllium plagiosum anti-CD20 VNARs
by: Qingyu Ren, et al.
Published: (2024-12-01)

Case Report: Simnotrelvir/Ritonavir are effective in shortening the course of prolonged SARS-CoV-2 infection during anti-CD20 maintenance therapy in patients with follicular lymphoma
by: Jing Yang, et al.
Published: (2025-08-01)

Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort
by: Andrea Serafin, et al.
Published: (2025-07-01)

Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma
by: Mihaljević Biljana, et al.
Published: (2008-01-01)

NOVEL DRUGS IN FOLLICULAR LYMPHOMA
by: Giuseppe Rossi, et al.
Published: (2016-11-01)

Monoclonal anti-CD20 antibodies in lymphomas therapy during the COVID-19 pandemic: pro and contra
by: K. A. Sychevskaya, et al.
Published: (2022-04-01)

Managing Follicular Lymphoma in the Elderly Population
by: Jiao Jie Cherie Tan, et al.
Published: (2023-01-01)

Follicular Lymphoma Presenting with Leptomeningeal Disease
by: Rubens Costa, et al.
Published: (2014-01-01)

INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
by: Francesco Zallio, et al.
Published: (2017-05-01)

Chylothorax as the Initial Manifestation of Follicular Lymphoma
by: Kyle Admire, et al.
Published: (2023-06-01)

Exploring Risk Factors for Follicular Lymphoma
by: Alexander J. Ambinder, et al.
Published: (2012-01-01)

CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
by: Ugo Testa, et al.
Published: (2024-01-01)

Follicular lymphoma: contemporary clinical management with a focus on recent therapeutic advances
by: Robert Kridel
Published: (2025-05-01)

The Comparison of De Novo Grade 3 Follicular Lymphoma and Transformed Grade 3 Follicular Lymphoma: Own Data
by: LV Plastinina, et al.
Published: (2017-10-01)

Cryptococcal meningitis in a human immunodeficiency virus negative patient with follicular lymphoma
by: Manjunath Nandennavar, et al.
Published: (2014-01-01)

Characterization of anti-canine CD20 antibody 4E1-7-B_f and comparison with commercially available anti-human CD20 antibodies.
by: Takuya Mizuno, et al.
Published: (2025-01-01)

CD7 Positive Diffuse Large B-Cell Lymphoma Arising in a Background of Follicular Lymphoma: A Case Report and Review of the Literature
by: Elham Vali Betts, et al.
Published: (2016-01-01)

CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma
by: Dan Zhu, et al.
Published: (2024-12-01)

Clinical characteristics of duodenal-type follicular lymphoma
by: Lu Wang, et al.
Published: (2025-07-01)

Primary follicular lymphoma of the breast – Case report
by: Bruno P Fogaça Duarte, et al.
Published: (2025-04-01)

Modern approaches to the treatment of relapsed follicular lymphoma
by: Yu. E. Ryabukhina, et al.
Published: (2022-07-01)

The landscape of T-cell engagers for the treatment of follicular lymphoma
by: Alfredo Rivas-Delgado, et al.
Published: (2024-12-01)

Severe atypical skin disease in two patients with CLL/SLL after BTKi treatment - a case report and literature review
by: Jingxin Zhou, et al.
Published: (2024-12-01)

Serbian lymphoma study group: Demografic characteristics of 257 patients with follicular lymphoma
by: Simonović Olivera, et al.
Published: (2015-01-01)

Microsatellite instability (MSI, EMAST) in the pathogenesis of follicular lymphoma
by: K. A. Sychevskaya, et al.
Published: (2021-06-01)

Perspectives for next generation sequencing in patients with follicular lymphoma
by: E. O. Kunevich, et al.
Published: (2023-12-01)

Pathologic splenic rupture in a patient with follicular lymphoma
by: Manoranjan Mahapatra, et al.
Published: (2011-01-01)

LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
by: Andrea Riccardo Filippi
Published: (2016-09-01)

Response Duration During Treatment of Patients with Follicular Lymphoma
by: Evelin Kiss, et al.
Published: (2025-06-01)

Composite t(14;18)-Negative Follicular Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma
by: John Patrick O’Neill, et al.
Published: (2018-01-01)

Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance
by: Christian Schmidt, et al.
Published: (2025-06-01)

Organising Pneumonia in a Patient Following Obinutuzumab for Follicular Lymphoma
by: Viral Nanda, et al.
Published: (2025-06-01)

Gastric Follicular Lymphomas Presenting as Subepithelial Tumors: Two Cases
by: Hyeong Jin Kim, et al.
Published: (2018-12-01)

Mosunetuzumab for relapsed or refractory follicular lymphoma: a case study
by: Ya. V. Krylova, et al.
Published: (2024-09-01)

Follicular Lymphoma Manifesting as an Isolated Colorectal Polyp‐Like Morphology
by: Yasuhiko Hamada, et al.
Published: (2025-05-01)

Co-occurrence of clonally related follicular lymphoma and histiocytic sarcoma
by: Sarah Haebe, et al.
Published: (2025-08-01)

Follicular lymphoma in children and adolescents: clinical, diagnostic and therapeutic features
by: T. T. Valiev, et al.
Published: (2023-09-01)